Search Results - "FRISHMAN, W. H"

Carvedilol by Frishman, William H

“…Carvedilol is a β-adrenoreceptor–antagonist drug with α 1 -adrenoreceptor–antagonist activity. It was approved in the United States in September 1995 for the…”
Get full text

Thyroid hormone and cardiovascular disease by Gomberg-Maitland, Mardi, Frishman, William H.

“…Thyroid hormone directly affects the heart and peripheral vascular system. The hormone can increase myocardial inotropy and heart rate and dilate peripheral…”
Get full text

Serotonin and the heart by Frishman, W H, Grewall, P

“…Serotonin is a naturally occurring vasoactive substance that has diverse cardiophysiological effects. These effects can be explained by the existence of…”
Get more information

Women, myocardial infarction, and dementia in the very old by ARONSON, M. K, OOI, W. L, MORGENSTERN, H, HAFNER, A, MASUR, D, CRYSTAL, H, FRISHMAN, W. H, FISHER, D, KATZMAN, R

“…Dementia is a major public health problem among the very old. Available information on incidence and prevalence is sparse and variable; however, there appears…”
Get full text

Sodium Ion/Hydrogen Ion Exchange Inhibition: A New Pharmacologic Approach to Myocardial Ischemia and Reperfusion Injury by Levitsky, Josh, Gurell, Daniel, Frishman, William H.

“…Over the past few years, it has been shown that the cardiac myocyte plasma membrane sodium ion/hydrogen ion exchanger (NHE) plays an important role in the…”
Get full text

Co-enzyme Q10: a new drug for cardiovascular disease by Greenberg, S, Frishman, W H

“…Co-enzyme Q10 (ubiquinone) is a naturally occurring substance which has properties potentially beneficial for preventing cellular damage during myocardial…”
Get more information

Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris by Frishman, William H, Glasser, Stephen, Stone, Peter, Deedwania, Prakash C, Johnson, Mary, Fakouhi, T.Daniel

“…This multicenter, randomized, double-blind, parallel group, placebo lead-in, placebo-controlled study compared the antianginal and anti-ischemic effects of…”
Get full text

Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease by Frishman, W H, Huberfeld, S, Okin, S, Wang, Y H, Kumar, A, Shareef, B

“…Serotonin, or 5-hydroxytryptamine, is a naturally-occurring vasoactive substance found primarily in the brain, enterochromaffin tissue, and blood platelets. It…”
Get more information

Novel antiplatelet therapies for treatment of patients with ischemic heart disease : inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor by FRISHMAN, W. H, BURNS, B, ATAC, B, ALTURK, N, ALTAJAR, B, LERRICK, K

“…Blood platelets play essential roles in normal coagulation and in coronary atherosclerotic disease and its complications. Various antiplatelet therapies,…”
Get full text

Twenty-four—hour ambulatory electrocardiography in elderly subjects: Prevalence of various arrhythmias and prognostic implications (report from the Bronx Longitudinal Aging Study) by Frishman, William H., Heiman, Mark, Karpenos, Alexander, Ooi, Wee Lock, Mitzner, Anne, Goldkorn, Ronen, Greenberg, Stephen

“…Functional, ambulatory, community-dwelling subjects ( n = 423, aged 75 to 85 years) underwent baseline 24-hour ambulatory electrocardiography (ECG)…”
Get full text

Raloxifene, a New Selective Estrogen Receptor Modulator by Goldfrank, Deborah, Haytoglu, Tahir, Frishman, William H., Mohammad, Zalt

“…There is evidence from observational studies that estrogen replacement therapy in postmenopausal women can reduce the rates of morbidity and mortality of…”
Get full text

Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy by Eberhardt, R T, Kevak, R M, Kang, P M, Frishman, W H

“…Through the multiple actions of angiotensin II (AII), the renin-angiotensin system (RAS) participates in cardiovascular homeostasis. Angiotensin II acts by…”
Get more information

Matrix Metalloproteinases and Coronary Artery Disease: A Novel Therapeutic Target by Celentano, Diane C., Frishman, William H.

“…Matrix metalloproteinases (MMP) are a family of enzymes that selectively digest individual components of the extracellular matrix. Their function has been…”
Get full text

Secondary prevention of myocardial infarction: Role of β-adrenergic blockers and angiotensin-converting enzyme inhibitors by Frishman, William H., Cheng, Angela

“…β-Blockers reduce cardiovascular death and reinfarction in patients with a history of myocardial infarction (MI), and angiotensin-converting enzyme (ACE)…”
Get full text

Comparison of Self-Report, Hospital Discharge Codes, and Adjudication of Cardiovascular Events in the Women’s Health Initiative by Heckbert, Susan R., Kooperberg, Charles, Safford, Monika M., Psaty, Bruce M., Hsia, Judith, McTiernan, Anne, Gaziano, J. Michael, Frishman, William H., Curb, J. David

“…Limited information is available from large clinical investigations about the agreement among sources of diagnoses for endpoints. The authors used data from…”
Get full text

Bile acid sequestrants by Ast, M, Frishman, W H

“…The bile acid sequestrants, cholestyramine and colestipol, are the drugs of choice for the treatment of patients with hypercholesterolemia caused by increases…”
Get more information

Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension by Frishman, W H, Fuksbrumer, M S, Tannenbaum, M

“…Since the late 1970s, topical beta-adrenergic blockers have been the drugs of choice in treating ocular hypertension and associated glaucoma. The currently…”
Get more information

Angiotensin II receptor antagonists: a new approach to blockade of the renin-angiotensin system by Kang, P M, Landau, A J, Eberhardt, R T, Frishman, W H

“…A-II exerts its activity on various target tissues by binding to its receptors. The discovery of local RASs and A-II receptors within various tissues has…”
Get more information

Matrix Metalloproteinases and Abdominal Aortic Aneurysms: A Potential Therapeutic Target by Sinha, Sanjai, Frishman, William H.

“…Abdominal aortic aneurysm (AAA) is a leading cause of death in the United States, and there is no effective treatment in the early course of disease. Therapy…”
Get full text

Chelation Therapy in Cardiovascular Disease: Ethylenediaminetetraacetic Acid, Deferoxamine, and Dexrazoxane by Elihu, Nadia, Anandasbapathy, Sharmila, Frishman, William H.

“…This review was conducted to assess whether there is sufficient evidence for the clinical use of chelation therapy in cardiovascular disease based on original…”
Get full text